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uriﬁed cytolytic T lymphocyte (CTL) proteases gran-
zyme (gzm)A and gzmB with sublytic dose of per-
forin (perf) initiate distinct proapoptotic pathways.
Their physiological relevance in CTL-mediated target cell
apoptosis is elusive. Using ex vivo virus-immune CD8
 
 
 
 T
cells from mice deﬁcient in perf, gzmA and/or gzmB, and
the Fas-resistant EL4.F15 tumor target cell, we show that (a)
CTL from gzmA
 
 
 
/
 
 
 
 or gzmB
 
 
 
/
 
 
 
 mice similarly induced
early proapoptotic features, such as phosphatidyl serine
(PS) exposure on plasma membrane, 
 
  
 
m
 
 loss, and re-
active oxygen radical generation, though with distinct
P
 
kinetics; (b) CTL from gzmA
 
 
 
/
 
 
 
 but not from gzmB
 
 
 
/
 
 
 
 mice
activate caspase 3 and 9; (c) PS exposure induced by CTL
from gzmA
 
 
 
/
 
 
 
 or gzmB
 
 
 
/
 
 
 
 mice is prevented, respectively,
by caspase inhibitors or by reactive oxygen scavengers
without interfering with target cell death; and (d) all gzm-
induced apoptotic features analyzed depend critically on
perf. Thus, perf is the principal regulator in CTL-mediated
and gzm-facilitated intracellular processes. The ability of
gzmA and gzmB to induce multiple independent cell death
pathways may be the hosts response to circumvent evasion
strategies of pathogens and tumors.
 
Introduction
 
Cytolytic leukocytes, Natural Killer (NK) and CD8
 
 
 
 T (cyto-
toxic T lymphocyte [CTL]) cells, are key components of the
hosts immune system against intracellular parasites and tumors.
NK and CTL exert their biological activity via two distinct
mechanisms. One is the synthesis and release of soluble medi-
ators such as IFN-
 
 
 
 (Boehm et al., 1997), TNF-
 
 
 
 (Vassalli,
1992), and interleukins (Biron, 1994), which may act proximal
and distal to the effector cell. The other is direct cytolysis and
induction of programmed cell death, apoptosis, in target cells
by either or both of two cytolytic pathways (Kagi et al., 1994;
Lowin et al., 1994). One is the Fas pathway involving the Fas
ligand (FasL) on the effector cell engaging the Fas receptor
(Fas or CD95) on the target cell (Rouvier et al., 1993; Nagata
and Golstein, 1995; Krammer, 1999). The other, executed
via the granula exocytosis pathway, is mediated by perforin
(perf; Podack, 1986; Henkart, 1994) and the two principal
granzymes (gzm), gzmA and gzmB (Simon and Kramer, 1994;
Tschopp, 1994). These components are stored in cytoplasmic
granules and are released into the immunological synapse
formed between effector cells and their targets (Podack, 1986;
Henkart, 1994; Stinchcombe et al., 2001). Although gzmA
and gzmB can get access to target cells independent of perf
via the mannose 6-phosphate receptor pathway or by other
means (Motyka et al., 2000; Trapani et al., 2003; Dressel et
al., 2004), their delivery to the cytosol and/or nucleus, where
they initiate alternative proteolytic processes to trigger apop-
tosis, is critically dependent on perf (Froelich et al., 1996;
Trapani et al., 1998).
Significant advances in our understanding of the molecular
basis for gzmA- and gzmB-induced cell death are based on
experiments using the mast-cell exocytosis model (Nakajima et
al., 1995) and from in vitro studies using purified effector mol-
ecules. It was concluded that gzmB initiates cell death through
various pathways, either involving activation of caspases, di-
rectly or indirectly, and resulting in disruption of mitochondrial
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integrity (Barry et al., 2000; Heibein et al., 2000; Sutton et al.,
2000, 2003; Alimonti et al., 2001; Goping et al., 2003; Metkar
et al., 2003), by derepressing the endonuclease CAD (Thomas
et al., 2000; Sharif-Askari et al., 2001) or by cleaving key
structural proteins in the nuclear membrane or cytoskeleton
(Browne et al., 2000; Zhang et al., 2001a,b). In contrast, gzmA
seems to induce apoptosis by caspase-independent pathways
(Beresford et al., 1999; Shresta et al., 1999). Besides other sub-
strates of gzmA, like lamins (Zhang et al., 2001a) and histones
(Zhang et al., 2001b), a special target seem to be the endoplas-
mic reticulum–associated SET complex (Fan et al., 2002). This
complex contains three gzmA substrates, the nucleosome as-
sembly protein SET, the DNA bending protein HMG-2, and
the base excision repair endonuclease Ape1. The SET complex
also contains the tumor suppressor protein pp32 and the DNase
NM23-H1, the latter of which is released from inhibition by
gzmA cleavage of SET and translocates to the nucleus (Fan et
al., 2003a). Furthermore gzmA-mediated proteolysis of Ape1
interferes with its known oxidative repair function for DNA
(Fan et al., 2003b).
These findings, principally obtained with purified effec-
tor molecules, emphasize the complexity of intracellular events
triggered by gzmA and gzmB. However, it is unclear to what
extent these in vitro observations reflect the biologically rele-
vant interaction of NK and CTL with target cells in vivo. In
particular, factors such as the quality of the proteins involved,
the way and context of their delivery, and/or their accessibility
to cellular compartments may play a crucial role in the out-
come of cytolytic function. The present work uses ex vivo–
derived virus-immune CD8
 
 
 
 T cells from mice with targeted
gene defects in perf or gzmA and/or gzmB to examine for the
first time the apoptotic pathways activated by CTL via the two
gzms in an in vitro cytotoxic assay using Fas-resistant tumor
target cells.
 
Results
 
Perf-mediated cytotoxicity of EL4.F15 
by CTL: loss of plasma membrane 
integrity and mitochondrial membrane 
potential is similarly and independently 
induced by gzmA and gzmB
 
To study a physiologically relevant model for granule exocyto-
sis–executed apoptotic cell death, in particular mediated by
gzms and independent of Fas, we used an in vitro CTL-target
cytotoxic assay. Ex vivo–derived virus-immune CD8
 
 
 
 T cells
(day eight after infection) from B6 mice or those deficient in
gzm(s) (gzmA
 
 
 
/
 
 
 
, gzmB
 
 
 
/
 
 
 
, and gzmA
 
 
 
B
 
 
 
/
 
 
 
) or perf (perf
 
 
 
/
 
 
 
),
infected with LCMV 8 d before, were used as effector cells. As
target cell, the tumor cell line EL4.F15 was chosen because it is
Fas resistant and at the same time sensitive to both gzmA- and
gzmB-induced apoptosis (Pardo et al., 2002). Confirming previ-
ous studies, splenocytes from 8-d LCMV-immune B6, gzmA
 
 
 
/
 
 
 
,
and gzmB
 
 
 
/
 
 
 
 mice contained similar numbers (11, 6, and 9%,
respectively) of gp33/D 
 
b
 
tetramer
 
 
 
/CD8
 
 
 
 T cells (Fig. 1 Aa). As
shown previously (Simon et al., 1997; Pardo et al., 2002), en-
riched CD8
 
 
 
 T cells from all three mouse strains readily induced
specific nucleolysis in gp33-pulsed EL4.F15 target cells (4-h as-
say), which was similar in magnitude for B6 and gzmA
 
 
 
/
 
 
 
 and
somewhat lower for gzmB
 
 
 
/
 
 
 
 T cells (Fig. 1 Ab).
Changes of cellular parameters occurring in EL4.F15
cells were analyzed after incubation with LCMV-immune
CD8
 
 
 
 T cells (2 h), by gating effector/target mixtures for CD8
negative cells. CD8
 
 
 
 T cell populations from B6, gzmA
 
 
 
/
 
 
 
,
and gzmB
 
 
 
/
 
 
 
 mice similarly induced loss of plasma mem-
brane integrity of gp33-pulsed EL4.F15 cells, as monitored by
exposure of phosphatidyl serine (PS) at the plasma membrane
and incorporation of propidium iodide (PI). This finding is re-
vealed by the fact that numbers of annexinV/PI-positive cells
was increased in gp33-pulsed as compared with mock-treated
targets (51, 40, and 40% vs. 9, 14, and 13% for B6, gzmA
 
 
 
/
 
 
 
,
and gzmB
 
 
 
/
 
 
 
 T cells, respectively; Fig. 1 Ac). Gliotoxin, a
hydrophobic fungal metabolite with apoptotic potential for
mammalian cells, served as positive control for induction of
the aforementioned parameters (Waring et al., 1999; Fig. 1 Ac).
Furthermore, upon specific CTL–target cell interaction (2 h),
all three CD8
 
 
 
 T cell populations induced severe mitochon-
drial perturbation in EL4.F15 targets. This result can be de-
duced by the comparable reduction of the mitochondrial trans-
membrane potential (
 
  
 
m
 
; 88 to 33%, 83 to 42%, and 81 to
45% for B6, gzmA
 
 
 
/
 
 
 
, and gzmB
 
 
 
/
 
 
 
 T cells, respectively) and
an increase in the generation of reactive oxygen species
(ROS), when mock-treated were compared with gp33-pulsed
EL4.F15 cells (3 to 38%, 4 to 35%, and 3 to 38% for B6,
gzmA
 
 
 
/
 
 
 
, and gzmB
 
 
 
/
 
 
 
 T cells, respectively; Fig. 1 Ad). The
protoionophore, carbonyl cyanide m-chlorophenylhydrazone
served as positive control for 
 
  
 
m
 
 loss in EL4.F15 cells (Fig.
1 Ad). The data suggest that CTL-induced loss of plasma
membrane and mitochondrial integrity can be elicited to the
same extent by gzmA or gzmB and independently of each
other. However, when tested at earlier time points of CD8
 
 
 
 T
cell–target cell interaction (i.e., at 30 or 60 min) loss of
plasma membrane and mitochondrial integrity was more pro-
nounced with B6 and gzmA
 
 
 
/
 
 
 
 as compared with gzmB
 
 
 
/
 
 
 
CD8
 
 
 
 T cells (Fig. 1 Ae). Moreover, at these two time points
but not later (2 h), annexinV reactivity preceded membrane
permeability with B6 and gzmA
 
 
 
/
 
 
 
 effectors.
 
Induction of loss of plasma membrane 
integrity and mitochondrial membrane 
potential elicited by CTL via gzmA or 
gzmB is dependent on perf
 
To determine if loss of plasma membrane and mitochondrial
integrity in EL4.F15 target cells induced by gzmA- or gzmB-
deficient CTL is dependent on perf, ex vivo–derived (day
eight after infection) and CD8-enriched LCMV-immune
splenic T cells from B6, perf
 
 
 
/
 
 
 
, and gzmA
 
 
 
B
 
 
 
/
 
 
 
 mice were
tested under the same conditions (2 h) for their potential to in-
duce the same apoptotic parameters described in the previous
paragraph. Effector cell populations from all three mouse
strains contained similar numbers of gp33/D 
 
b
 
tetramer
 
 
 
/CD8
 
 
 
T cells (10, 11, and 9% for B6, perf
 
 
 
/
 
 
 
, and gzmA
 
 
 
B
 
 
 
/
 
 
 
 T
cells, respectively; Fig. 1 Ba). As previously found (Simon et
al., 1997; Pardo et al., 2002), only CD8
 
 
 
 T cells from B6, but 
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not from perf
 
 
 
/
 
 
 
 or gzmA
 
 
 
B
 
 
 
/
 
 
 
, mice were able to induce
specific nucleolysis in EL4.F15 target cells (Fig. 1 Bb, 4-h as-
say). Therefore, target cell survival upon interaction with ei-
ther B6-, perf
 
 
 
/
 
 
 
-, or gzmA
 
 
 
B
 
 
 
/
 
 
 
-derived CTL was inversely
proportional to nucleolysis (Fig. 1 Bc). From the three effec-
tor cell populations, only CD8
 
 
 
 T cells from B6 mice readily
induced loss of plasma membrane integrity in EL4.F15 target
cells, whereas CD8
 
 
 
 T cells from perf
 
 
 
/
 
 
 
 or gzmA
 
 
 
B
 
 
 
/
 
 
 
mice were, if at all, only marginally effective (Fig. 1 Bd).
Similarly, only CD8
 
 
 
 T cells from B6 mice were able to opti-
Figure 1. PS exposure, mitochondrial depo-
larization, and ROS generation is induced by
gzmA
 /  and gzmB
 /  but not by perf
 /  and
gzmA B
 /  CTL. EL4.F15 cells were incu-
bated with ex vivo virus-immune CD8
  cells
(MACS selected,  95% CD8
  cells) from ei-
ther B6, gzmA
 / , or gzmB
 /  (A) or from B6,
perf 
 / , or gzmA B
 /  (B) mice, in the pres-
ence or absence of the LCMV peptide gp33.
(Aa) percentage of virus-specific CD8
  cells,
determined by staining with gp33-labeled tet-
ramers (H-2D
b; tet-PE). (Ab) EL4.F15 cells
were incubated with effector cells for 4 h
(open symbols,  gp33; closed symbols,
 gp33) at different effector/target ratios,
and DNA fragmentation was analyzed by
3H-thymidine  release. (Ac and Ad) EL4.F15
cells were incubated with effector cells for 2 h
at a 10:1 effector/target ratio. Subsequently,
PS exposure on plasma membrane (annexin-
V-FITC) and PI uptake (c) and, in parallel,   m
loss (3,3-dihexyloxacarbocyanin [DiOC6(3)]
staining) and ROS generation (2-hydroxiethi-
dine [2-HE]; d) were analyzed by three-color
flow cytometry in the cell population negative
for CD8 expression (target cells). EL4.F15
cells were also incubated with 200  M glyo-
toxin (c) or 200  M carbonyl cyanide m-chlo-
rophenylhydrazone (CCCP; d) as positive
controls for PS exposure and   m loss, re-
spectively. Numbers indicate percentage of
cells in each quadrant. (Ae) EL4.F15 cells
were incubated with effector cells for 30, 60,
or 120 min at a 10:1 effector/target ratio,
and PS exposure and PI uptake or   m loss
and ROS generation were analyzed as de-
scribed in Ac and Ad. Data presented are the
mean of at least three independent experiments
and are given as the difference of percentages
in the presence versus the absence of gp33  
SD. (B) a, same as Aa; b, same as Ab; c, tar-
get cell death (open symbols,  gp33; closed
symbols,  gp33) was monitored after incuba-
tion of CML for 2 h at an effector/target cell
ratio of 10:1 by the cell survival assay. Bd,
same as Ac; Be, same as Ad.JCB • VOLUME 167 • NUMBER 3 • 2004 460
mally induce   m loss (from 82 to 59%) and ROS generation
(from 8 to 25%, in the absence vs. presence of gp33 peptide).
In contrast,   m loss and ROS generation was much lower
when CD8
  T cells from gzmA B
 /  mice were used (  m:
83 to 77%, ROS: 7 to 13%; in the absence vs. presence of
gp33 peptide) and not detectable with CTL from perf
 /  mice
(Fig. 1 Be). These data demonstrate that for gzm-facilitated
loss of plasma membrane and mitochondrial integrity in
EL4.F15 target cells during specific CTL attack, the presence
of perf is critical. In addition, in the absence of gzmA and
gzmB, perf is able on its own or together with as yet unknown
factors to induce, though only slightly,   m loss and ROS
generation, however without affecting the survival of target
cells (Fig. 1 B, e vs. c).
Figure 2. B6 and gzmA
 /  but neither gzmB
 / , perf
 / , nor gzmA B
 / 
CTL are able to induce caspase 3 and 9 activity. EL4.F15 cells were incu-
bated with ex vivo virus-specific CD8
  cells (MACS selected,  95%
CD8
  cells) from either B6, gzmA
 / , or gzmB
 /  (A) or from B6, perf
 / ,
or gzmA B
 /  (B) mice (2 h, 10:1 effector/target ratio), in the presence
(red and green) or absence (black) of the LCMV peptide gp33, as indi-
cated. Activation of caspase 3 was monitored with either an FITC-labeled
mAb against the active form of the enzyme (Aa and Ba) or the specific
fluorescent substrates SRH-DEVD-fmk (Ab and Bb), by two-color flow cy-
tometry in the cell population negative for CD8 expression (target cells)
as described in Materials and methods. Similarly, activation of caspase 9
was monitored with the specific fluorescent substrates FAM-LEHD-fmk (Ac
and Bc). CMLs were also developed in the presence of a blocking mAb
anti-FasL, where indicated (Aa, bottom, dark blue; and Ab and Ac, middle, dark blue), and in the presence of the caspase 3 (100  M Z-DEVD-fmk; b) or
caspase 9 (100  M Z-LEHD-fmk; c) inhibitors (Ab, Ac, Bb, and Bc, bottom, orange). Numbers correspond to the percentage of cells positive for the label-
ing in each case, indicated by the horizontal bars shown in the top panels.GRANZYMES-INDUCED CELL DEATH EXERTED BY CTL • PARDO ET AL. 461
CTL-mediated activation of caspase 3 
and 9 is dependent on gzmB but not 
gzmA
LCMV-immune CD8
  T cells from B6, gzmA
 / , and gzmB
 / 
mice were incubated with gp33-pulsed or mock-treated
EL4.F15 target cells (2 h), and activation of intracellular cas-
pase 3 was assessed using the mAb C92-605. Fig. 2 A shows
that effector cells from B6 and gzmA
 /  mice specifically and
comparably induced activation of caspase 3 in  30% of target
cells, whereas those from gzmB
 /  mice did not (Fig. 2 Aa,
top). The presence of blocking anti-FasL mAb did not alter ac-
tivation of caspase 3 by the two CD8
  T cell populations (Fig.
2 Aa, bottom). This excludes a contribution of the Fas path-
way and suggests that the CTL-mediated effect is solely elic-
ited via the exocytosis pathway (Pardo et al., 2002). When
caspase activation in EL4.F15 cells was tested under similar
conditions by applying intracellular staining with the caspase
3–specific agent SRH-DEVD-fmk, comparable results were
obtained (Fig. 2 Ab, top). Gp33-pulsed but not mock-treated
target cells incubated with either B6- or gzmA
 / -derived
LCMV-immune CD8
  T cells stained positive for active cas-
pase 3 (44 vs. 6% and 60 vs. 15%, respectively). Again, the
presence of blocking anti-FasL mAb did not alter activation of
caspase 3 by B6 and gzmA
 /  CTL (Fig. 2 Ab, middle,  
gp33 peptide). In both cases, pretreatment of targets with the
specific inhibitor Z-DEVD-fmk (Fig. 2 Ab, orange) leads to a
drastic reduction in positively staining cells (Fig. 2 Ab, bot-
tom). Surprisingly and in contrast to results obtained using the
specific mAb for active caspase 3, a small fraction of gp33-
pulsed EL4.F15 cells (30 vs. 17% for mock-treated cells) also
stained positive with SRH-DEVD-fmk after incubation with
gzmB
 /  LCMV-immune CD8
  T cells (Fig. 2 Ab, top).
However, the number of EL4.F15 cells staining for active cas-
pase 3 were only marginally reduced by the specific inhibitor
Z-DEVD-fmk (Fig. 2 Ab, bottom). This finding indicates that
the apparent caspase 3 activation observed by using the fluo-
rescent substrate (but not the mAb) is due to unspecific bind-
ing of the substrate to a molecule distinct from caspase 3 (Am-
stad et al., 2001).
The CTL-induced intracellular activation of caspase 9
was monitored by using the specific agent FAM-LEHD-fmk.
As shown in Fig. 2 Ac (top) LCMV-immune CD8
  T cells
from B6 and gzmA
 /  mice specifically activated caspase 9 in
a fraction of EL4.F15 cells (gp33 vs. mock peptide: 52% vs.
28% and 56% vs. 21%, respectively). In both cases, activation
was totally inhibited upon pretreatment of EL4.F15 cells with
the specific inhibitor of caspase 9, Z-LEHD-fmk (Fig. 2 Ac,
bottom, orange). Again, incubation of EL4.F15 cells with
gzmB
 / -derived LCMV-immune CD8
  T cells resulted in an
increase of target cells staining with FAM-LEHD-fmk (Fig. 2
Ac, top). However, this effect was not or only marginally al-
tered upon pretreatment with the specific inhibitor Z-LEHD-
fmk (Fig. 2 Ac, bottom, orange), indicating that FAM-LEHD-
fmk binds to a protein(s) distinct from caspase 9 (Amstad et
al., 2001). Specific activation of caspase 9 by B6 and gzmA
 / 
CTL was not inhibited in the presence of anti-FasL mAb (Fig.
2 Ac, middle).
CTL-mediated activation of caspase 3 
and 9 by gzmB is strictly dependent on 
perf
To determine whether or not CTL-induced and gzmB-facili-
tated activation of caspase 3 is also dependent on perf,
EL4.F15 cells were cocultured with LCMV-immune CD8
  T
cells from B6, perf
 / , and gzmA B
 /  mice. Fig. 2 Ba
shows that only CTL from B6 mice were able to specifically
induce activation of caspase 3, as monitored with the mAb
C92-605 in a fraction of EL4.F15 cells (23 vs. 2% for
mock-treated cells). Similar results were obtained when SRH-
DEVD-fmk was used to detect active caspase 3 (Fig. 2 Bb,
top). As expected, the number of cells staining positive with
SRH-DEVD-fmk, upon incubation with B6 CTL, was dras-
tically reduced after preincubation of EL4.F15 cells with
Z-DEVD-fmk (Fig. 2 Bb, bottom, orange). A considerable in-
crease in positive staining cells for SRH-DEVD-fmk was also
seen after incubation with LCMV-immune gzmA B
 / -
derived CD8
  T cells (Fig. 2 Bb, top). However, fluorescence
was not altered after preincubation of cells with Z-DEVD-fmk
(Fig. 2 Bb, bottom), indicating that SRH-DEVD-fmk binds to
a protein(s) distinct from caspase 3.
Similarly, only effector cells from B6 mice were able to
specifically induce activation of caspase 9, as observed with
FAM-LEHD-fmk (52 vs. 15% for mock-treated cells; Fig. 2
Bc, top), which was inhibited in the presence of Z-LEHD-fmk
(52 to 36%; Fig. 2 Bc, bottom, orange). In contrast, LCMV-
immune CD8
  T cells from perf
 /  mice did not induce activa-
tion of caspase 9. Furthermore, the increase in intracellular
staining of EL4.F15 cells for FAM-LEHD-fmk after incuba-
tion with gzmA B
 / -derived LCMV-immune CD8
  T cells
(47 vs. 15% for mock-treated cells) was not inhibited by
Z-LEHD-fmk (47 vs. 53%; Fig. 2 Bc, bottom).
GzmB-activated caspases contribute to 
loss of plasma membrane integrity and 
mitochondrial membrane potential
We tested if in the course of CTL-mediated cytolysis, activa-
tion of caspases is essential for gzm-induced PS exposure on
plasma membrane, cell death (PI incorporation),   m loss,
and ROS generation. For this purpose, LCMV-immune CD8
 
T cells from B6, gzmA
 / , or gzmB
 /  mice were incubated
with EL4.F15 cells in the presence of the universal caspase in-
hibitor Z-VAD-fmk or with the caspase 3 inhibitor Z-DEVD-
fmk. As shown in Fig. 3 (A and B; mean of three independent
experiments), the number of annexinV
  and PI
  cells was
drastically reduced by either Z-DEVD-fmk or Z-VAD-fmk
when gzmA
 / -derived CTL were used, only partially in the
presence of B6 CTL, and not at all with gzmB
 /  CTL. Fur-
thermore,   m loss and ROS generation induced by B6- and
gzmA
 / - but not gzmB
 / -derived CTL were also reduced,
though only partially, in the presence of Z-DEVD-fmk or
Z-VAD-fmk (Fig. 3, C and D). These data suggest that CTL-
mediated induction of plasma membrane perturbation is criti-
cally dependent on functional active caspases when elicited by
gzmB but not by gzmA and reveals caspase-dependent and
-independent mechanisms of gzmB-induced mitochondrial de-JCB • VOLUME 167 • NUMBER 3 • 2004 462
polarization. In both cases, a DEVD-sensitive caspase, in par-
ticular caspase 3, may be the main executor of these caspase-
dependent processes.
Synergy between caspase 3 and 9 in 
CTL-mediated target cell lysis
To clarify if the level of active caspase 3 generated during
CTL-mediated cytolysis is regulated by caspase 9, which is
only produced in its active form after mitochondrial perturba-
tion and cytochrome c release (Li et al., 1997; Boatright et al.,
2003), LCMV-immune CD8
  T cells from B6 and gzmA
 / 
mice were incubated with EL4.F15 cells in the presence of the
caspase 9 inhibitor Z-LEHD-fmk. As shown in Fig. 3 E,
Z-LEHD-fmk (orange) considerably reduced specific activation
of caspase 3, as monitored with mAb C92-605. This result
was independent of the effector cell population used (from 58
to 25% for B6 CTL and from 55 to 24% for gzmA
 /  CTL;
Fig. 3 E, bottom).
To see whether or not the generation of functional active
caspase 9 as monitored with the specific substrate FAM-
LEHD-fmk was dependent on previous activation of caspase
3, aliquots of the cytotoxicity assay (CML) cultures derived
from B6 and gzmA
 /  mice were incubated in the presence of
inhibitors for either caspase 3 (Z-DEVD-fmk, gray) or caspase
9 (Z-LEHD-fmk, orange). Fig. 3 F shows that specific induc-
tion of caspase 9 activity by both CTL populations (top) is
completely inhibited by Z-LEHD-fmk (from 36 to 13% for B6
CTL and from 36 to 14% for gzmA
 /  CTL; Fig. 3 F, middle)
and also by Z-DEVD-fmk (from 36 to 16% for B6 CTL and
from 36 to 17% for gzmA
 /  CTL; Fig. 3 F, bottom). To-
gether, these results suggest that in CTL-mediated cytolysis
activation of caspase 3 is a prerequisite for caspase 9 activa-
tion and that the generation of the former caspase is amplified
by the latter.
Effect of oxidative stress on gzmA- and 
gzmB-induced loss of plasma membrane 
integrity and mitochondrial membrane 
potential
As shown in the first paragraph of Results, incubation of
EL4.F15 cells with either B6, gzmA
 / , or gzmB
 /  LCMV-
immune CD8
  T cells leads to ROS generation. To evaluate
the requirement for ROS generation in gzmA- and gzmB-
mediated apoptotic processes, the respective CML cultures were
incubated with targets (2 h) previously treated with the antiox-
idant N-acetylcysteine (NAC) and tested for the annexinV
 /
PI
  phenotype,   m loss, and presence of active caspases 3
and 9. As expected, ROS formation is similarly suppressed af-
ter pretreatment of EL4.F15 cells with NAC, irrespective of
the source of CTL (Fig. 4 D). The number of cells with the
annexinV
 /PI
  phenotype was significantly reduced in NAC-
treated as compared with mock-treated EL4.F15 cells after
culture with B6- and gzmA
 / -derived CTL and reduced to
near background level when cultured with gzmB
 / -derived
Figure 3. Caspase inhibitors completely block
PS exposure induced by gzmA-deficient CTL.
(A–F) EL4.F15 cells were incubated with ex
vivo virus-specific CD8
  cells (MACS selected,
 95% CD8
  cells) from B6, gzmA
 / , or
gzmB
 /  mice for 2 h at a 10:1 effector/target
ratio in the presence or absence of the LCMV
peptide gp33. (A–D) CML cultures were incu-
bated in the presence or absence of 100  M
of the pan caspase inhibitor Z-VAD-fmk or the
caspase 3 inhibitor Z-DEVD-fmk. Subsequently,
PS exposure on plasma membrane (annexin-V-
FITC; A) and PI uptake (B) and, in parallel,
  m loss (DiOC6(3) staining; C) and ROS gen-
eration (2-HE; D) were analyzed by three-color
flow cytometry in the cell population negative
for CD8 expression (target cells). Results are
the mean of three independent experiments
and are given as the difference of percentages
in the presence or absence of gp33   SD.
(E and F) Inhibition of caspase 3 or 9 activity
reduces, respectively, caspase 9 or 3 activa-
tion induced by B6 and gzmA
 /  CTL. Cas-
pase 3 activity was analyzed using an FITC-
labeled mAb against the active form of the
enzyme (E), whereas caspase 9 activity was
analyzed by using the specific fluorescent
substrate FAM-LEHD-fmk (F) by two-color flow
cytometry in the cell population negative for
CD8 expression (target cells). CMLs were also
developed in the presence of the caspase 3
(100  M Z-DEVD-fmk; F, bottom, gray) or cas-
pase 9 (100  M Z-LEHD-fmk; E, bottom, or-
ange; and F, middle, orange) inhibitors. Num-
bers correspond to the percentage of cells
positive for the labeling in each case, indicated
by the horizontal bars shown in the top panels.GRANZYMES-INDUCED CELL DEATH EXERTED BY CTL • PARDO ET AL. 463
CTL (Fig. 4, A and B). NAC protected EL4.F15 cells only
partially from   m loss, independent of the effector cell pop-
ulation (Fig. 4 C). Pretreatment of EL4.F15 cells with NAC
had no effect on the activation of caspase 3, as monitored by
mAb C92-605 fluorescence (Fig. 4 E, left), but resulted in
considerably reduced activation of caspase 9 after incubation
with either B6- or gzmA
 / -derived CTL, as determined by
staining with FAM-LEHD-fmk (Fig. 4 E, right). Upon addi-
tion of both NAC and LEHD-fmk to cultures of B6 CTL and
EL4.F15 target cells, inhibition of caspase 3 activation did not
exceed that obtained with LEHD-fmk alone (Fig. 3 E and not
depicted). The fact that suppression of plasma membrane per-
turbation (annexin
 /PI
  phenotype) by NAC is more pro-
nounced when gzmB
 / - compared with gzmA
 / -derived
CTL are used suggests that the generation of ROS is critical in
gzmA-induced cell surface membrane perturbation, but less so
in gzmB-mediated but caspase-dependent processes.
CTL-mediated cleavage of Ape-1 is 
strictly dependent on perf but only 
partially on gzmA and/or gzmB
To test if the apurinic endonuclease-1, Ape-1, a known substrate
of gzmA (Fan et al., 2003b), is cleaved during CTL-mediated
lysis of targets, LCMV-immune CD8
  T cells from either B6,
gzmA
 / , or gzmB
 /  mice were incubated with gp33-pulsed
EL4.F15 cells (4 h), and changes in Ape-1 expression were
tested by monitoring intracellular staining of CD8-negative tar-
get cells with FITC-labeled Ape-1–reactive polyclonal antibody
H-300. As shown in Fig. 5 A, 95% of mock-treated EL4.F15
cells stained with the antibody preparation. When gp33-pulsed
target cells were incubated with either B6-, gzmA
 / -, or
gzmB
 / -derived CTL, the numbers of Ape-1–positive cells
were significantly reduced, compared with control mock-treated
targets (from 85 to 65%, 74 to 48%, and 76 to 54%, respec-
tively; Fig. 5 A). When, in a further experiment (Fig. 5 B), B6
CTL were compared with perf
 /  and gzmA B
 /  CTL using
similar conditions, the number of target cells staining for Ape-1
were also significantly reduced by gzmA B
 /  CTL (from 77
to 66%), though to a lesser extend compared with B6 CTL
(from 79 to 54%). No reduction occurred with perf
 / -derived
CTL. These results indicate that cleavage of Ape-1 in targets,
following CTL attack, is strictly dependent on perf and also oc-
curs, at least partially, in the absence of both gzms.
Caspase activation or oxidative stress is 
not essential for CTL-mediated cell death
To further evaluate the requirement of caspase activation or
ROS in gzm-mediated target cell death, LCMV-immune CD8
 
T cells from either B6 gzmA
 /  or gzmB
 /  mice were incu-
bated with gp33 peptide or mock-treated EL4.F15 cells (Fig. 6
A, top) or in the presence of either Z-VAD-fmk or Z-DEVD-
fmk (Fig. 6 A, middle) or after pretreatment of target cells with
NAC (Fig. 6 A, bottom). Target cell survival was estimated by
extended culture under growth conditions unsuitable for CTL
and by adding fresh inhibitors every 24 h. Neither treatment of
target cells with Z-VAD-fmk nor Z-DEVD-fmk was able to res-
cue target cells from death, irrespective of the CTL population
used. Furthermore, pretreatment of EL4.F15 cells with NAC
did not prevent their death by either B6, gzmA
 / , or gzmB
 / 
CD8
  T cells. The lack of inhibition of target cell death was
most likely not due to loss of inhibitor activity of any of the
three agents. This is indicated by the finding that supernatant of
cell cultures still retained most of the inhibitor activity after 24 h
of culture, as tested by its effect on either anti-Fas mAb-medi-
ated killing of L1210.Fas cells (Fig. 6 Ba, for Z-VAD-fmk and
Z-DEVD-fmk activities) or on generation of gliotoxin-induced
ROS in EL4.F15 cells (Fig. 6 Bb, for NAC activity). However,
even with this control, the possibility that during CTL-mediated
apoptosis caspases were not completely inhibited and contrib-
uted to cell death cannot be formally excluded.
Discussion
The evolution of multiple strategies by intracellular pathogens
and transformed cells to evade the immune system has brought
Figure 4. PS exposure induced by gzmB
 /  CTL is blocked in the absence
of ROS, but mitochondrial depolarization is still observed. Gp33-pulsed
EL4.F15 cells were incubated with ex vivo virus-specific CD8
  cells
(MACS selected,  95% CD8
  cells) from wild-type B6, gzmA
 / , and/
or gzmB
 /  mice for 2 h at a 10:1 effector/target ratio, in the presence
or absence of the ROS scavenger NAC at 15 mM. PS exposure on
plasma membrane (annexin-V-FITC; A) and PI uptake (B) and, in parallel,
  m loss (DiOC6(3) staining; C) and ROS generation (2-HE; D) were an-
alyzed by three-color flow cytometry in the cell population negative for
CD8 expression. Results are the mean of two independent experiments
and are given as the difference of percentages in the presence or absence
of gp33 (SD was always lower that 5% of the mean). (E) Alternatively,
CML cultures were incubated in the absence (red or green) or presence
(blue) of NAC (15 mM). Caspase 3 activation was determined using an
FITC-labeled mAb against the active form of the enzyme (left), whereas
caspase 9 activity was determined by using the specific fluorescent sub-
strate FAM-LEHD-fmk (right) by two-color flow cytometry in the cell popu-
lation negative for CD8 expression (target cells). Numbers correspond to
the percentage of cells positive for the labeling in each case, indicated
by the horizontal bars.JCB • VOLUME 167 • NUMBER 3 • 2004 464
about a multitude of effector mechanisms for CTL, the biologi-
cally most relevant being the ability to induce apoptosis. By us-
ing ex vivo–derived CTL from mice deficient in either gzmA
and/or gzmB or perf, we show here that induction of cell death,
as monitored by a cell survival assay, only occurs when at least
one of the two gzms, gzmA and gzmB, is present and that perf
is the ultimate regulator of the underlying processes. The data
reveal that gzmA and gzmB independently induce several sim-
ilar or distinct morphological and biochemical events now rec-
ognized as characteristic features of the apoptotic program, in-
cluding PS exposure at the plasma membrane, mitochondrial
depolarization, caspase activation, and Ape-1 cleavage. More-
over, results obtained with inhibitors of caspases or ROS gen-
eration suggest that individual gzm-facilitated proapoptotic
pathways are effective on their own in inducing cell death but
that the latter process is amplified by their concerted action.
The finding that gzmA B
 /  but not perf
 / -derived CTL ex-
press residual potential to induce certain apoptotic features in-
dicates the involvement of additional effector molecules, be-
sides gzmA and gzmB, in perf-mediated cell death. However,
these factors do not contribute to cell death of the target used in
the present study.
The findings that during CTL-target cell killing, perf-
induced plasma membrane disturbance in EL4.F15 target
cells, as revealed by PS exposure, occurs faster with gzmB as
compared with gzmA and that in the case of gzmB annexinV
reactivity precedes membrane permeabilization are new.
Together with the fact that this proapoptotic program was
greatly repressed by universal and specific caspase inhibitors
only in case of gzmA
 / , but not gzmB
 / , CTL supports re-
cent findings with purified perf and gzms (Sarin et al., 1998;
Heibein et al., 1999) and suggests that activation of cas-
pase(s) contributes, together with other pathways (i.e., mito-
chondria; see below in Discussion), to the accelerated pro-
cess by gzmB. This finding also emphasizes the notion that
CTL-mediated apoptosis elicited in the presence of both
gzms is greatly influenced by the quality of the individual
target cell (Pardo et al., 2002).
The result that PS exposure on EL4.F15 cells was only
marginally increased upon incubation with gzmA B
 /  CTL
makes it unlikely that additional molecules, besides gzmA and
gzmB, contribute to plasma membrane perturbation. However,
because the targeted null mutation of gzmB also affects other
downstream genes in the domain, including gzmC, -D, -E, -F,
and -G (Pham et al., 1996), their involvement in this CTL-
mediated pathway cannot be excluded. Especially as it was re-
cently shown that purified gzmC together with perf induces PS
exposure on plasma membrane in a process distinct from gzmB
(Johnson et al., 2003). In addition, other gzms, termed orphan
gzms (Grossman et al., 2003), such as gzmK and gzmM, with
cellular expression patterns distinct from gzmA and gzmB may
also facilitate this proapoptotic process (Shresta et al., 1997;
MacDonald et al., 1999; Kelly et al., 2004).
The finding that the ROS scavenger NAC completely
blocks the induction of PS exposure on plasma membrane of
EL4.F15 cells by gzmB
 /  but not gzmA
 /  CTL is novel and
indicates that ROS synergize with gzmA but not gzmB in CTL-
induced plasma membrane perturbation. This finding is remark-
able in the context of a recent paper demonstrating the coupling
of actin cytoskeleton dynamics and the production of ROS in cell
death of yeast and most probably also mammalian cells (Gourlay
et al., 2004). Thus, we speculate that gzmA is destabilizing the
actin cytoskeleton in target cells by cleaving a yet unknown sub-
strate, leading to depolarization of mitochondrial membrane and
ROS generation, and that the latter amplifies PS exposure at the
plasma membrane, thereby accelerating cell death and/or uptake
of targets by phagocytes via the PS receptor (Savill and Fadok,
2000; Danial and Korsmeyer, 2004). Alternatively, as the SET
complex, a major substrate of gzmA (Fan et al., 2002, 2003a,b),
is associated with the ER, gzmA may initiate apoptotic processes
by perturbing ER membrane and inducing Ca
2  release from ER
stores. This cell death pathway is elicited by interorganelle flow
of Ca
2  and facilitated by direct physical connections between
ER and mitochondria (Newmeyer and Ferguson-Miller, 2003),
leading to caspase-independent   m loss and ROS generation
(Demaurex and Distelhorst, 2003; Orrenius et al., 2003).
Figure 5. Ape-1 degradation is induced by
B6, gzmA
 / , gzmB
 / , and gzmA B
 /  but
not perf
 /  CTL. EL4.F15 cells were incubated
with ex vivo virus-specific CD8
  cells (MACS
selected,   95% CD8
  cells) from wild-type
B6, gzmA
 / , or gzmB
 /  mice (A) or from
perf
 /  or gzmA B
 /  mice (B) for 4 h at a
10:1 effector/target ratio in the presence
(green) or absence (blue) of gp33 peptide.
Subsequently, Ape-1 expression was ana-
lyzed in the cell population negative for CD8
expression by two-color flow cytometry. Red
histograms indicate the cells labeled with the
control isotype antibody. Numbers corre-
spond to the percentage of cells positive for
the labeling in each case, indicated by the
horizontal bars.GRANZYMES-INDUCED CELL DEATH EXERTED BY CTL • PARDO ET AL. 465
Mitochondria are implicated in CTL-mediated pathways
of apoptosis, but the contribution of   m loss and ROS gener-
ation to this process is still controversial (MacDonald et al.,
1999; Barry et al., 2000; Heibein et al., 2000; Danial and Kors-
meyer, 2004). The data that gzmA
 /  and gzmB
 / , but not
perf
 / , CTL induce   m reduction and ROS generation in
EL4.F15 target cells to a similar extent indicates that both pro-
cesses are dependent on perf, but are similarly and indepen-
dently elicited by gzmA or gzmB. In addition, the finding that
activation of the mitochondrial pathway is inhibited, at least
partially, by Z-VAD-fmk and DEVD-fmk in the case of
gzmA
 /  but not gzmB
 /  CTL argues that gzmA and gzmB
induce   m loss via distinct molecular pathways. Furthermore,
it indicates that gzmA induces mitochondrial depolarization in
a caspase-independent manner, whereas gzmB may use both
caspase-dependent and -independent pathways and supports
previous findings (Heibein et al., 1999; Barry et al., 2000; Ali-
monti et al., 2001; Pinkoski et al., 2001; Goping et al., 2003;
Sutton et al., 2003). Understanding how these complex pro-
cesses induced by gzmA and gzmB interrelate and facilitate
target cell lysis by CTLs requires further analysis.
The present demonstration that CTL from B6 and
gzmA
 / , but not from gzmB
 / , perf
 / , or gzmA B
 / ,
mice induced activation of caspase 3 and 9 in EL4.F15 cells
corroborates and extends previous work with purified proteins
and CTL on the differential effect of gzmA and gzmB in the
perf-facilitated caspase pathway (Heibein et al., 1999; Pardo et
al., 2002; Goping et al., 2003; Metkar et al., 2003; Sutton et al.,
2003). However, because the targeted null mutation of gzmB
also affects other downstream gzm genes in the domain
(gzmC–G; Pham et al., 1996), their putative effect on these
processes cannot be assessed. Activation of caspase 3 and 9 by
wild-type B6 and gzmA
 /  CTL was completely blocked by
pretreatment of EL4.F15 cells with the caspase 3–specific in-
hibitor Z-DEVD-fmk. In contrast, using similar conditions, the
caspase 9–specific inhibitor Z-LEHD-fmk completely inhibited
activation of caspase 9, but only partially that of caspase 3.
Thus we conclude that in gzmB-mediated cytolysis, activation
of caspase 3 is an early event in target cell apoptosis and is a
prerequisite for the generation of the caspase 9 apoptosome—
most likely via mitochondrial permeabilization—which in turn
cleaves additional procaspase 3. Such an amplification loop be-
tween caspase 3 and 9 has been proposed before with purified
gzmB and perf (Metkar et al., 2003).
Ape-1, a multifunctional component of the SET com-
plex (Fan et al., 2003b) expressing both endonuclease activity
and the potential to repair oxidative damage to DNA and oxi-
dative changes to transcription factors (Bennett et al., 1997;
Hirota et al., 1997; Evans et al., 2000), is similarly cleaved in
EL4.F15 cells, irrespective of whether CTL from either B6,
gzmA
 / , or gzmB
 /  mice are used as effectors. Cleavage of
Ape-1 was also observed, though at reduced levels, with
gzmA B
 /  CTL, but was absent in perf
 /  CTL. Fan et al.
(2003b) have shown that gzmA specifically binds Ape-1 and
destroys its known oxidative repair function by proteolytic
cleavage. Our data indicate that CTL contain additional enzy-
matic activity(ies) distinct from gzmA and gzmB–G, such as
gzmK (Shresta et al., 1997), which is able to block cellular re-
pair in a perf-dependent manner. However, this gzmA/gzmB-
independent process does not seem to be relevant for the in-
duction of cell death, as demonstrated by survival of EL4.F15
cells after their incubation with gzmA B
 /  CTL (Fig. 2 C).
The lack of inhibition of CTL-mediated cell death of
EL4.F15 cells, as monitored by target cell survival, by either
the universal caspase inhibitor Z-VAD-fmk, the caspase 3 in-
hibitor DEVD-fmk, or the antioxidant agent NAC when effec-
tor cells from B6, gzmA
 / , or gzmB
 /  mice were used em-
phasizes the multitude of gzmA- and gzmB-facilitated effector
pathways elicited by CTL. Moreover, the data reiterate the no-
tion that gzmB-induced cell death similarly occurs via caspase-
Figure 6. Cell death induced by B6, gzmA
 / , and
gzmB
 /  CTL is not affected by caspase inhibitors or
ROS scavengers. (A) EL4.F15 cells were incubated
with ex vivo LCMV-immune CD8
  T cells (MACS se-
lected,   95% CD8
  cells) from B6, gzmA
 / , or
gzmB
 /  mice for 4 h at a 10:1 effector/target ratio,
in the presence (opened symbols) or absence (closed
symbols) of the viral protein gp33 (top panels). Alter-
natively, gp33-pulsed EL4.F15 cells were incubated
with the respective effector cell populations in the
presence of either 100  M Z-VAD-fmk (square), 100
 M Z-DEVD-fmk (middle, triangle), or 15 mM NAC
(bottom, circle). Subsequently, target cell death was
monitored by propagating CML cultures at conditions
unsuitable for CTL. (Ba) L1210.Fas cells were cul-
tured in the presence or absence of  Fas antibody
(Jo-2; 1  g/ml) for 20 h; cell cultures supplemented
with Jo-2 were in addition treated with either Z-VAD-
fmk or Z-DEVD-fmk (100  M) or with 24-h SN of ef-
fector cell-target cell cultures (A; B6 CD8
  T cells
 EL4.F15   gp33). Cell death was analyzed by Try-
pan blue exclusion and results are expressed as the
mean     SD of two independent experiments. (Bb)
EL4.F15 cells were cultured in the presence or absence
of gliotoxin (100 or 200  M) for 3 h; cell cultures
supplemented with gliotoxin were in addition treated with either 15 mM NAC or with 24 h SN of effector cell-target cell cultures (A; B6 CD8
  T cells
 EL4.F15   gp33). Generation of ROS was analyzed by 2-HE staining. Data shown are representative of three independent experiments.JCB • VOLUME 167 • NUMBER 3 • 2004 466
dependent and -independent intracellular processes, whereas
all gzmA-induced cell death events are caspase independent
and also occur in the absence of ROS generation. This enor-
mous versatility of CTL probably evolved in response to the
multiple strategies of pathogens and tumors to evade immune-
mediated apoptosis (Benedict et al., 2002; Igney and Krammer,
2002; Trapani and Smyth, 2002).
In conclusion, the present study is the first account
on gzmA- and/or gzmB-initiated intracellular processes during
CTL-target cell interaction, a model of which is schematically
represented in Fig. 7. Although the biological significance of
the multiple overlapping and nonoverlapping proapoptotic path-
ways observed with ex vivo–derived CTLs reported herein for
their in vivo performance is still elusive, this type of in vitro cy-
totoxic assay should help to provide a physiologically relevant
perspective for gzm-mediated control of infections and cancer.
Materials and methods
Mouse strains
Inbred C57BL/6 (B6) and mouse strains deficient for perf (perf
 / ),
gzmA (gzmA
 / ), gzmB (gzmB
 / ), and gzmA B (gzmA B
 / ) bred on
the B6 background were maintained at the Max-Planck-Institut für Immun-
biologie and analyzed for their genotypes as described previously (Si-
mon et al., 1997; Balkow et al., 2001). Male mice of 8 to 10 wk of age
were used in all experiments and were conducted in accordance with the
ethical guidelines of the Federation of European Laboratory Animal Sci-
ence Association.
Generation of ex-vivo CD8
  cells
Mice were infected with 10
5 pfu LCMV-WE i.p. according to established
protocols (Balkow et al., 2001). On day eight after infection, CD8
  cells
were positively selected from spleen using  -CD8-MicroBeads (Miltenyi
Biotec) with an autoMACS (Miltenyi Biotec) and resuspended in MEM/
2 mg/ml BSA before use in cytotoxic assays. Purity of selected CD8
  cells
was assessed by FACS staining and found to be between 95–98%.
Target cells
The mouse tumor lines EL4.F15 and L1210.Fas were used as target cells
(Pardo et al., 2002). Cell lines were cultured in MEM supplemented with
10% heat-inactivated FCS and 2-mercaptoethanol (10
 5 M) at 7% CO2,
as described previously (Pardo et al., 2002).
CMLs
The DNA release assay and the target cell survival assay was performed
as described previously (Müllbacher et al., 1999). For LCMV-immune CTL-
mediated lysis, target cells were pretreated with the synthetic peptide
KAVYNTATC (gp33) as described previously (Balkow et al., 2001).
Online supplemental material
For analysis of intracellular apoptotic processes in target cells, effector
and target cells were incubated at a ratio of 10:1 (effector/target) and al-
iquots of CML cultures (10
5 targets/experimental point) were stained with
anti-CD8 mAb. CD8-negative targets were subsequently analyzed for
proapoptotic processes and cell death, including plasma membrane disin-
tegration, mitochondrial perturbation, caspase activation, Ape-1 cleav-
age, and thymidine release/cell survival. Online supplemental material
consists of the following methods: 
3[H] DNA release and cell survival as-
says; analysis of inhibitor stability; flow cytometry, including cell surface
phenotype analysis, exposure/incorporation of annexin-V/PI, and re-
duction of mitochondrial membrane potential/generation of ROS (i.e.,
↓  m/ROS); activation of caspases; and proteolytic degradation of Ape-1.
Online supplemental material is available at http://www.jcb.org/cgi/
content/full/jcb.200406115/DC1.
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